People

Gillian Russell is counsel in the firm’s FDA and Life Sciences practice. Gillian advises pharmaceutical, biotechnology and medical device companies on a variety of U.S. Food and Drug Administration (FDA) and healthcare regulatory compliance matters, including product advertising and promotion, federal healthcare compliance programs, clinical trial regulation, and FDA enforcement actions.  In addition, Gillian regularly counsels clients in the cosmetics industry and has advised clients in the food industry. Gillian’s practice also focuses on regulatory requirements imposed by the U.S. Drug Enforcement Administration (DEA), the Federal Trade Commission (FTC) and state boards of pharmacy.

Gillian graduated from the University of Virginia School of Law, where she served as Executive Editor for the Virginia Environmental Law Journal and as a Hardy Cross Dillard fellow for legal research and writing. Gillian earned her B.A. magna cum laude from Princeton University, where she was a four-year member of the swimming team. 

 

Full Bio

Credentials

J.D., University of Virginia

B.A., Princeton University, magna cum laude

District of Columbia

New Jersey

Pennsylvania

Matters

“Industry Update – New FDA Guidance on Social Media,” FX Conferences (September 2014).

“The New Drug Approval Process: New Drug Research and Development,” FDLI Introduction to Drug Law and Regulation, Washington, D.C. (April 2, 2014).

Icon close

Close

Matters

“Industry Update – New FDA Guidance on Social Media,” FX Conferences (September 2014).

“The New Drug Approval Process: New Drug Research and Development,” FDLI Introduction to Drug Law and Regulation, Washington, D.C. (April 2, 2014).

Matters

“Industry Update – New FDA Guidance on Social Media,” FX Conferences (September 2014).

“The New Drug Approval Process: New Drug Research and Development,” FDLI Introduction to Drug Law and Regulation, Washington, D.C. (April 2, 2014).

Icon close

Close

Matters

“Industry Update – New FDA Guidance on Social Media,” FX Conferences (September 2014).

“The New Drug Approval Process: New Drug Research and Development,” FDLI Introduction to Drug Law and Regulation, Washington, D.C. (April 2, 2014).

Credentials

J.D., University of Virginia

B.A., Princeton University, magna cum laude

District of Columbia

New Jersey

Pennsylvania